Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching

BACKGROUND: Although dexmedetomidine (DEX) is widely used during the perioperative period in patients with hepatocellular carcinoma (HCC), its clinical effects on liver function and postoperative inflammation are unclear. This study aimed to explore effects of DEX on postoperative liver function and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqiang, Li, Yi-ran, Shi, Yumiao, Li, Xiaoying, Luo, Jiamei, Zhang, Yiqi, Qi, Bo, Wu, Feixiang, Sun, Yuming, Pan, Zhiying, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160666/
https://www.ncbi.nlm.nih.gov/pubmed/37152009
http://dx.doi.org/10.3389/fonc.2023.1108559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160666/
https://www.ncbi.nlm.nih.gov/pubmed/37152009
http://dx.doi.org/10.3389/fonc.2023.1108559

Ejemplares similares